Skip to main content

Advertisement

Log in

Chronic myeloid leukaemia with BCR–ABL fusion genes located to both chromosomes 9, cyclic leukocytosis and nodal T-lymphoblastic transformation – durable complete remission following imatinib therapy

  • Spotlight Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Atallah E, Talpaz M, O'Brien S, Rios MB, Guo JQ, Arlinghaus R et al. Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy. Cancer 2002; 94: 2996–2999.

    Article  CAS  Google Scholar 

  2. Branford S, Hughes TP, Rudzki Z . Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics. Br J Haematol 1999; 107: 587–599.

    Article  CAS  Google Scholar 

  3. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003; 17: 2474–2486.

    Article  CAS  Google Scholar 

  4. Ye CC, Echeverri C, Anderson JE, Smith JL, Glassman A, Gulley ML et al. T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumor. Hum Pathol 2002; 33: 770–773.

    Article  Google Scholar 

  5. Hughes TP, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley ML et al. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med 2003; 349: 1423–1432.

    Article  CAS  Google Scholar 

  6. Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers GJ, Van der Plas D et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer 1993; 8: 237–245.

    Article  CAS  Google Scholar 

  7. Vieira L, Alves AC, Marques B, Reis I, Jorge G, Ambrosio AP et al. Insertion of the 5′ part of BCR within the ABL gene at 9q34 in a Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet 1999; 114: 17–21.

    Article  CAS  Google Scholar 

  8. Michalova K, Zemanova Z, Bkezinova J, Moravcova J, Oltova A, Sobotka J et al. Location of the BCR/ABL fusion genes on both chromosomes 9q34 in Ph negative chronic myeloid leukemia. Leuk Lymphoma 2002; 43: 1695–1700.

    Article  CAS  Google Scholar 

  9. Takahashi N, Miura I, Ohshima A, Utsumi S, Nimura T, Hashimoto K et al. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia. Cancer Genet Cytogenet 1996; 89: 166–169.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I H Dufva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dufva, I., Karle, H., Brondum-Nielsen, K. et al. Chronic myeloid leukaemia with BCR–ABL fusion genes located to both chromosomes 9, cyclic leukocytosis and nodal T-lymphoblastic transformation – durable complete remission following imatinib therapy. Leukemia 19, 671–673 (2005). https://doi.org/10.1038/sj.leu.2403662

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403662

  • Springer Nature Limited

This article is cited by

Navigation